Stocks Health care LSTA
NASDAQ · Health careLisata Therapeutics, Inc. (LSTA)
Lisata Therapeutics, Inc. brought in $100K of revenue over the twelve months to June 30, 2026, down 90.7% from a year earlier. It posted a net loss of $14.6M. In fiscal 2024 capital spending exceeded operating cash flow by $16M. At June 30, 2026 it held $10.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Lisata Therapeutics, Inc. does
Lisata Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LSTA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | $170K | -$16.6M | -$1.91 | -$16M |
| 2024 | $1M | -$20M | -$2.40 | -$19.4M |
| 2023 | $0 | -$20.8M | -$2.58 | -$20M |
| 2022 | $0 | -$54.2M | -$10.47 | -$21.5M |
| 2021 | n/a | -$27.5M | -$7.45 | -$22.3M |
| 2020 | n/a | -$8.2M | -$7.90 | -$8.8M |
Where LSTA ranks in Health care
Dividends
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2014 | n/a | $0 | n/a |
| 2013 | n/a | $0 | n/a |
| 2012 | n/a | $327.7K | n/a |
| 2011 | n/a | $0 | n/a |
| 2011 | n/a | $222.9K | n/a |
Latest SEC filings
What Lisata Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 17, 2026
- August 26, 2026Passive stake (5% or more) SCHEDULE 13G
- August 6, 2026
- August 4, 2026
- July 28, 2026Tender offer (amended) SC TO-T/A
- July 24, 2026
- July 21, 2026Response to tender offer (amended) SC 14D9/A
- July 17, 2026
- July 17, 2026Response to tender offer (amended) SC 14D9/A
- July 17, 2026Tender offer (amended) SC TO-T/A
Who owns LSTA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Branham Justin Earl13G, passive | 5.1% | August 26, 2026 |
Largest institutional holders
Insiders
Questions about LSTA
What does Lisata Therapeutics, Inc. do?
Lisata Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LSTA.
Is Lisata Therapeutics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $14.6M on revenue of $100K.
How much revenue does Lisata Therapeutics, Inc. make?
Over the twelve months to June 30, 2026 Lisata Therapeutics, Inc. reported revenue of $100K. That is 90.7% less than a year earlier.
When did Lisata Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the acquisition or sale completed from September 17, 2026.
Similar companies
Compare LSTA with
Follow LSTA
Get an email when Lisata Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow LSTA: get an email when it filesWhere the numbers come from
Financial figures are the values Lisata Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.